ReviewInternational journal of peptide research and therapeutics2023

Deferoxamine has the Potential to Improve the COVID-19-Related Inflammatory Response in Diabetic Patients.

Motahareh Zeinivand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.